top of page

Diagnostics

Crossroads: the role of biomarkers in the management of lumps in the breast

Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis

Breast cancer risk in papilloma patients:
Osteopontin splice variants indicate prognosis

Nuclear osteopontin-c is a prognostic breast
cancer marker

RNA blood levels of osteopontin splice variants are cancer markers

Osteopontin-c is a selective marker of breast cancer

Osteopontin splice variants are differential predictors of breast cancer treatment responses

An osteopontin splice variant induces anchorage independence in human breast cancer cells

Meta‐analysis of Osteopontin splice variants in cancer

Anti‐osteopontin autoantibodies in various types of cancer

bottom of page